hsd_id_Glycine_max_2976	XP_003516408.1; XP_006576481.1; XP_006602689.1	421; 421; 435	Pfam	PF00650, PF03765; PF00650, PF03765; PF03765, PF00650	CRAL/TRIO domain, CRAL/TRIO, N-terminal domain; CRAL/TRIO domain, CRAL/TRIO, N-terminal domain; CRAL/TRIO, N-terminal domain, CRAL/TRIO domain	IPR001251, IPR011074; IPR001251, IPR011074; IPR011074, IPR001251	CRAL-TRIO lipid binding domain, CRAL/TRIO, N-terminal domain; CRAL-TRIO lipid binding domain, CRAL/TRIO, N-terminal domain; CRAL/TRIO, N-terminal domain, CRAL-TRIO lipid binding domain

>XP_003516408.1
MDTTSSPMSLQTQKTNFQDLPEASPKPYKKGIVATLMGGAGSFKEDNYFVSLLRSSEKKALQELKEKLKSSFEDSPSDASMWGIPLLGGDDKADVILLKFLRARDFRIGDAHHMLLKCLSWRKEFGADTILEEDLGFNKELEGVVAYMQGYDKEGHPVCYNAYGVFKDKEMYERVFGDEEKLKKFLRWRVQVLERGIKVLHFKPGGVNSLIQVTDLKDMPKRELRVASNQILSLFQDNYPEMVARKIFINVPWYFSMLYSMFSPFLTQRTKSKFVISKEGNAAETLYKFMRPEDIPVQYGGLNRPSDLQNGPPKPVSEFRIKGGEKVNIQIEGIEAGATITWDIVVGGWDLEYSAEFVPNAEGSYTIAVEKPRKMGASEEAIHNSFTSKESGKMVLSVDNTASRRKKVAAYRYVVRKSSTI
>XP_006576481.1
MMDTTSSPLSLQTQKTTFQELPEASPKPYKKGIVATLMGGGLFKEDNYFVSLLRSSEKKALQELKTKLKASFEDSPSDASMWGIPLLGGDDKADVILLKFLRARDFRVGDAHHMLMKCLSWRKEFGADTILEEEFLGLKELEGVVAYMQGYDKEGHPVCYNAYGVFKDKEMYERVFGDDEKLKKFLRWRVQVLERGIKVLHFKPGGVNSLIQVTDLKDMPKRELRVASNQILSLFQDNYPEMVARKIFINVPWYFSMLYSMFSPFLTQRTKSKFVISKEGNAAETLYKFMRPEDIPVQYGGLNRPSDLQNGPPKPASEFTIKGGEKVNIQIEGIEAGATITWDIVVGGWDLEYSAEFVPNAEGSYTIAVEKPRKMGASEEAIHNSFTSKESGKMVLSADNTASRRKKVAAYRYFVRKSSTI
>XP_006602689.1
MQRFHLGLPHSPPMDTSTPFQDLPEASPKPFFKKTTLTSFIMSSTPSFKEDTYYISHLKSSEKKALQDLKNKLQSSYSSTPSMWGVPLLNNNNADNADVILLKFLRARDFRVHDALSMLLKCLSWRTEFGADNIVDEELGGFKELEGVVAYTHGYDREGHPVCYNAYGVFKDREMYENVFGDEEKLKKFLRWRVQVLERGVRMLHFKPGGVNSLIQVTDLKDMPKRELRIASNQILSLFQDNYPEMVARKIFINVPWYFSVLYSMFSPFLTQRTKSKFVISKEGNAAETLYKFIRPENIPVRYGGLSRPSDLENGPPKPASEFTVKGGEIVNIQIEGIESGATITWDIVVGGWDLEYSAEFVPIAQGSYTLAVDKARKIEATEEAIHNSFTSKEAGKMVLSVDNSASRKKKVAAYRYFVRKSSTPTPSEVQLSPK